ReviewThe American journal of the medical sciences2012
Extraparenchymal neurocysticercosis in the United States.
Review in The American journal of the medical sciences, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Comparative analysis of parenchymal and extraparenchymal neurocysticercosis: a 10-year experience from northern Thailand.BMC infectious diseases · 2026Article
- Persistent MRI Abnormalities After Successful Treatment of Subarachnoid and Intraventricular Neurocysticercosis: A Case Series.Neurology. Clinical practice · 2025Article
- Silent Intruder: Unusual Presentation of Neurocysticercosis in an HIV-Infected Patient from the Far Northern Brazilian Amazon.Medicina (Kaunas, Lithuania) · 2024Article
- Isolated neurocysticercosis of the spine presenting with low back pain and cauda equina syndrome: a case report.Spinal cord series and cases · 2022Article
- A Rare Case Report of Ruptured Cyst Presenting With Acute Meningitis in an Untreated Neurocysticercosis.Cureus · 2021Article
- Article
- Mathematical model of the life cycle of taenia-cysticercosis: transmission dynamics and chemotherapy (Part 1).Theoretical biology & medical modelling · 2018Article
- Extraparenchymal neurocysticercosis: Demographic, clinicoradiological, and inflammatory features.PLoS neglected tropical diseases · 2017Article
- New diagnostic criteria for neurocysticercosis: Reliability and validity.Annals of neurology · 2016Article
- Racemose neurocysticercosis.Surgical neurology international · 2016Article
- Conservative management of neurocysticercosis in a patient with hematopoietic stem cell transplantation: a case report and review.Transplant infectious disease : an official journal of the Transplantation Society · 2015Review
- Third-ventricular neurocysticercosis: hydraulic maneuvers facilitating endoscopic resection.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2014Article
- Neurocysticercosis, meningioma, and silent corticotroph pituitary adenoma in a 61-year-old woman.Case reports in pathology · 2012Article
- Extraparenchymal neurocysticercosis in the United States: a case report.Journal of medical case reports · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Neurocysticercosis (NCC) is endemic in the developing world but is becoming more common in the United States because of immigration. Although NCC is pleomorphic in its presentation, extraparenchymal NCC may be challenging to diagnose and treat. Extraparenchymal NCC is probably more frequent than previously thought. Neurologists and neuroradiologists in the United States are often unaware of the pretreatment/post-treatment radiographic patterns of extraparenchymal NCC and the potentially poor prognosis if not correctly diagnosed and managed. The review of this condition is important given increasing incidence in the United States.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.